C08 Caffeine is a modifier of age at onset in Huntington's disease

Duru, C; Simonin, C; Richard, F; Hincker, P; Génin, M; Charles, P; Youssov, K; Burnouf, S; Azulay, J-P; Verny, C; Tranchant, C; Goizet, C; Defebvre, L; Sablonnière, B; Rousseau, M; Buée, L; Amouyel, P; Godefroy, O; Dürr, A; Bachoud-Lévi, A-C
September 2010
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA18
Academic Journal
Background Phenotypic expression is variable in Huntington's disease (HD). Mutation in the IT15/HD1 gene statistically predicts for the age at onset (AAO), but on an individual basis, repeat length accounts for about 60% of its variance supporting the fact that 40% of the remaining variance is due to additional genetic and/or environmental factors. Association of AAO with polymorphisms located in different genes (ex: ADORA2A) has been previously reported. In contrast, whether environmental factors are also able to influence AAO remain unknown. Caffeine is a non-selective antagonist of A2A receptors, selectively localised on striatal medium spiny neurons expressing enkephalin and dopaminergic D2 receptors, known to be the most vulnerable ones in HD. Interestingly, modulation of A2A receptors influence the pathophysiological outcome in experimental models of HD. Aims To determine the impact of caffeine on the AAO (primary endpoint) and the rates of functional, motor and cognitive decline (secondary endpoints) in HD patients. Methods 58 HD patients were included from eight sites over a 6 month period. Information about caffeine consumption was collected with a validated self-questionnaire. All patients were evaluated using the Unified Huntington's Disease Rating Scale. Factors influencing AAO were examined using a stepwise regression analysis. After adjustment of CAG repeat length, subjects were categorised into three group and we compared the mean of AAO between low end high consumers. Results We found a significant correlation between AAO and caffeine intake (r2=0.041; p=0.016): the highest caffeine intake was associated with the earlier AAO. Also, we demonstrated that caffeine influenced AAO with an advanced AAO of 6.9 years in high consumers compared with low consumers. However, we failed to demonstrate a relation between caffeine intake and the rate of functional, motor and cognitive decline. Conclusion Our findings suggest that caffeine could be the first environmental modifier of AAO in HD. It could have an important therapeutic impact as the modulation of A2A receptors may represent new strategies for treating HD.


Related Articles

  • Choreatische Bewegungsst�rungen. Kosinski, C.M.; Landwehrmeyer, B. // Nervenarzt;Sep2007, Vol. 78 Issue 0, p37 

    The differential diagnosis of chorea includes a growing number of rare diseases. This article gives hints on clinical differences and possible laboratory investigations which may help to identify the underlying disease. The majority of hereditary chorea cases are caused by Huntington's disease....

  • The role of tau in the pathological process and clinical expression of Huntington's disease. Vuono, Romina; Winder-Rhodes, Sophie; de Silva, Rohan; Cisbani, Giulia; Drouin-Ouellet, Janelle; Spillantini, Maria G.; Cicchetti, Francesca; Barker, Roger A.; REGISTRY Investigators of the European Huntington’s Disease Network // Brain: A Journal of Neurology;Jul2015, Vol. 138 Issue 7, p1907 

    Huntington's disease is a neurodegenerative disorder caused by an abnormal CAG repeat expansion within exon 1 of the huntingtin gene HTT. While several genetic modifiers, distinct from the Huntington's disease locus itself, have been identified as being linked to the clinical expression and...

  • Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease. Metzger, Silke; Bauer, Peter; Tomiuk, Jürgen; Laccone, Franco; DiDonato, Stefano; Gellera, Cinzia; Mariotti, Caterina; Lange, Herwig; Weirich-Schwaiger, Helga; Wenning, Gregor; Seppi, Klaus; Melegh, Bela; Havasi, Viktoria; Balikó, Laszlo; Wieczorek, Stefan; Zaremba, Jacek; Hoffman-Zacharska, Dorota; Sulek, Anna; Basak, A.; Soydan, Esra // Human Genetics;Sep2006, Vol. 120 Issue 2, p285 

    The expansion of a polymorphic CAG repeat in the HD gene encoding huntingtin has been identified as the major cause of Huntington’s disease (HD) and determines 42–73% of the variance in the age-at-onset of the disease. Polymorphisms in huntingtin interacting or associated genes are...

  • Refusing to provide a prenatal test: can it ever be ethical? Duncan, Rony E.; Foddy, Bennett; Delatycki, Martin B. // BMJ: British Medical Journal (International Edition);11/18/2006, Vol. 333 Issue 7577, p1066 

    Huntington's disease is an autosomal dominant lethal neurodegenerative disorder, with a mean age of onset of 37 years. There is no treatment that modifies the natural course of the disease. Prenatal genetic testing can raise difficult ethical issues for clinicians. The International Huntington...

  • Clinical Characteristics of Childhood-Onset (Juvenile) Huntington Disease: Report of 12 Patients and Review of the Literature. Gonzalez-Alegre, Pedro; Afifi, Adel K. // Journal of Child Neurology;Mar2006, Vol. 21 Issue 3, p223 

    Whereas adult-onset Huntington disease is a well-characterized clinical entity, childhood-onset cases have not received as much attention. In this report, the clinical, demographic, and genetic characteristics in 12 patients with childhood-onset Huntington disease are presented and compared with...

  • The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients. Metzger, Silke; Walter, Carolin; Riess, Olaf; Roos, Raymund A. C.; Nielsen, Jørgen E.; Craufurd, David; Nguyen, Huu Phuc // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The cause of Huntington disease (HD) is a polyglutamine repeat expansion of more than 36 units in the huntingtin protein, which is inversely correlated with the age at onset of the disease. However, additional genetic factors are believed to modify the course and the age at onset of HD....

  • The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington’s disease. Metzger, Silke; Bauer, Peter; Tomiuk, Juergen; Laccone, Franco; Didonato, Stefano; Gellera, Cinzia; Soliveri, Paola; Lange, Herwig; Weirich-Schwaiger, Helga; Wenning, Gregor; Melegh, Bela; Havasi, Victoria; Balikó, Lazlo; Wieczorek, Stefan; Arning, Larissa; Zaremba, Jacek; Sulek, Anna; Hoffman-Zacharska, Dorota; Basak, A.; Ersoy, Nagehan // Neurogenetics;Mar2006, Vol. 7 Issue 1, p27 

    An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of the expanded polyglutamine repeat is inversely correlated with the age-at-onset, additional genetic factors are thought to modify the...

  • Huntington's Disease.  // World Book Science Dataset;1/1/2009, p1 

    Huntington's Disease

  • Huntington Disease in a 9-Year-Old Boy: Clinical Course and Neuropathologic Examination. Wojaczyńska-Stanek, Katarzyna; Adamek, Dariusz; Marszal, Elżbieta; Hoffman-Zacharska, Dorota // Journal of Child Neurology;Dec2006, Vol. 21 Issue 12, p1068 

    Huntington disease is a dominantly inherited, neurodegenerative disorder, usually with onset in the fourth to fifth decade of life but in a small proportion of patients before the age of 20 years. The early-onset form, juvenile Huntington disease, is clinically different from that of more...

  • PGC-1alpha as modifier of onset age in Huntington disease. Taherzadeh-Fard, Elahe; Saft, Carsten; Andrich, Jürgen; Wieczorek, Stefan; Arning, Larissa // Molecular Neurodegeneration;2009, Vol. 4, p1 

    Although there is a strong correlation between CAG repeat length and age at onset (AO) of motor symptoms, individual Huntington disease (HD) patients may differ dramatically in onset age and disease manifestations despite similar CAG repeat lengths. This has led to a search for genetic factors...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics